CaptiREC (LRC-TriCEPS) experiment performed at Dualsystems

Dualsystems has performed an example of a CaptiREC (LRC-TriCEPSTM) experiment to identify the target receptor of Anti-EGFR-Antibody on human breast cancer cells (MDA-MB-23):

Positive control ligand (included in the kit): Insulin
Ligand of interest: Anti-human EGF Receptor Antibody
Cells: MDA-MB-231 human breast cancer cells

Detail on the experiment see here